Table 2.

Clinical outcomes at 1-month follow-up between the two groups

Items	Aspirin group (n = 139)	No-aspirin group (n = 249)	χ2	P
Hemorrhage, n (%)	1 (0.8)	3 (1.3)	0.005	0.944
BARC type 2	1 (0.8)	1 (0.4)	0.102	0.749
BARC type 5	0 (0.0)	2 (0.9)	0.102	0.749
Death, n (%)	5 (3.6)	7 (2.8)	0.184	0.668
Cardiac death	1 (0.8)	3 (1.3)	0.005	0.944
Aortic death	2 (1.5)	2 (0.9)	0.005	0.944
Other causes of death	2 (1.5)	2 (0.9)	0.005	0.944
Endoleak, n (%)	3 (2.3)	5 (2.2)	0.074	0.785
Recurrent dissection, n (%)	3 (2.3)	5 (2.2)	0.074	0.785
Myocardial infarction, n (%)	1 (0.8)	1 (0.4)	0.102	0.749
Cerebral infarction	0	0	–	–

BARC: Bleeding Academic Research Consortium; –: Not applicable.